Authors:
Larson, RA
Dodge, RK
Szatrowski, TP
Frankel, SR
Citation: Ra. Larson et al., Results of recent clinical trials in acute lymphoblastic leukemia by the cancer and leukemia group B, HEMAT BLOOD, 40, 2001, pp. 393-401
Citation: Tp. Szatrowski et al., Phase I trial of docetaxel (Taxotere) for patients with relapsed or refractory acute myeloid leukemia (AML), HEMAT BLOOD, 40, 2001, pp. 477-481
Authors:
Hensley, ML
Peterson, B
Silver, RT
Larson, RA
Schiffer, CA
Szatrowski, TP
Citation: Ml. Hensley et al., Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia: Analysis of cancer and leukemia Group B 9013, J CL ONCOL, 18(6), 2000, pp. 1301-1308
Authors:
Lee, EJ
George, SL
Caligiuri, M
Szatrowski, TP
Powell, BL
Lemke, S
Dodge, RK
Smith, R
Baer, M
Schiffer, CA
Citation: Ej. Lee et al., Parallel phase I studies of daunorubicin given with cytarabine and etoposide with or without the multidrug resistance modulator PSC-833 in previouslyuntreated patients 60 years of age or older with acute myeloid leukemia: Results of cancer and leukemia group B study 9420, J CL ONCOL, 17(9), 1999, pp. 2831-2839
Authors:
Hensley, ML
Schuchter, LM
Lindley, C
Meropol, NJ
Cohen, GI
Broder, G
Gradishar, WJ
Green, DM
Langdon, RJ
Mitchell, B
Negrin, R
Szatrowski, TP
Thigpen, JT
Von Hoff, D
Wasserman, TH
Winer, EP
Pfister, DG
Citation: Ml. Hensley et al., American Society of Clinical Oncology clinical practice guidelines for theuse of chemotherapy and radiotherapy protectants, J CL ONCOL, 17(10), 1999, pp. 3333-3355
Authors:
Levine, EG
Cirrincione, CT
Szatrowski, TP
Canellos, G
Norton, L
Henderson, IC
Citation: Eg. Levine et al., Phase II trial of topotecan in advanced breast cancer - A Cancer and Leukemia Group B study, AM J CL ONC, 22(3), 1999, pp. 218-222
Authors:
Czuczman, MS
Dodge, RK
Stewart, CC
Frankel, SR
Davey, FR
Powell, BL
Szatrowski, TP
Schiffer, CA
Larson, RA
Bloomfield, CD
Citation: Ms. Czuczman et al., Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and Leukemia Group B study 8364, BLOOD, 93(11), 1999, pp. 3931-3939
Authors:
Wetzler, M
Dodge, RK
Mrozek, K
Carroll, AJ
Tantravahi, R
Block, AW
Pettenati, MJ
Le Beau, MM
Frankel, SR
Stewart, CC
Szatrowski, TP
Schiffer, CA
Larson, RA
Bloomfield, CD
Citation: M. Wetzler et al., Prospective karyotype analysis in adult acute lymphoblastic leukemia: The Cancer and Leukemia Group B experience, BLOOD, 93(11), 1999, pp. 3983-3993